Showing results (371-380 of 490) with videos related to

Sort By:
Pageof 49
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patientsSatoshi Gando, Hideo Wada, Hidesaku Asakura, et al.
Intensive Care Medicine|September 2, 2024
Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsisMassimo Girardis, Sascha David, Ricard Ferrer, et al.
Critical Care Medicine|December 20, 2007
Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective surveySatoshi Gando, Daizoh Saitoh, Hiroshi Ogura, et al.
Thrombosis Research|September 9, 2008
Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsisSatoshi Gando, Daizoh Saitoh, Hiroshi Ogura, et al.
Thrombosis Research|September 29, 2009
Expert consensus for the treatment of disseminated intravascular coagulation in JapanHideo Wada, Hidesaku Asakura, Kohji Okamoto, et al.
Thrombosis and Haemostasis|January 10, 2009
Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and traumaShigeki Kushimoto, Satoshi Gando, Daizoh Saitoh, et al.
Thrombosis and Haemostasis|October 4, 2002
Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzeesArno H M Moons, Ron J G Peters, Hugo ten Cate, et al.
Lancet (London, England)|January 28, 2003
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialPhilip W Friederich, Christiaan P Henny, Embert J Messelink, et al.
Thrombosis and Haemostasis|October 17, 2007
The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the doseJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Thrombosis and Haemostasis|October 17, 2007
Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumonJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Pageof 49